Brand profile · Pharmaceutical Manufacturing

PT Etana Biotechnologies Indonesia

Jakarta-based PT Etana Biotechnologies Indonesia operates in Pharmaceutical Manufacturing. The record marks it privately held. It holds one address on record, all in Indonesia. Headcount on record is 417. Its latest round on record is Debt financing, with no amount recorded. It is listed alongside eight similar brands, mostly in Pharmaceutical Manufacturing.

LinkedIn

Profile live Privately Held Founded 2014 1 office country 2 funding rounds
Counted staff
417
self-reported 201–500 band
Founded
2014
12 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
2
Debt financing · Apr 2023
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

PT Etana Biotechnologies Indonesia established since 2014, engaged in manufacturing, R&D and marketing of recombinant gene-technology, monoclonal antibody (MAB’s) drugs and vaccines.

PT Etana Biotechnologies Indonesia has an international scale and advanced technology cooperating with known pharmaceutical companies to develop new products and markets.

Vision:

To become a biotech pharmaceutical company who provide better solution for better life through the features biology product with the best quality.

Mission:

To be an integrated biotech company in the business of manufacturing PIC/S standard and marketing of high quality and affordable biosimilars for Indonesia and other emerging countries.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary ID. Codes: ID.1 countryprimary IDID
Show as table
Countries1
Primary countryID

All codes: ID

Addresses

  • IDJl. Rawa Gelam V Blok L Kav 11-13 Kel. Jatinegara Kec. Cakung Kawasan Industri Pulogadung Jakarta Timur 13930; Jakarta , 13930Primary

Grid intelligence Members

Funding

Last round · 20 April 2023Amount not recordedDebt financing · investor: KFW DEG
Rounds2
Round typeDebt financing · non-equity funding
Amount (USD)not recorded
Stage ranknot recorded
Investors named1
Since last round2 yr 9 mo

Funding

2 funding roundsFunding timeline. Latest round 20 Apr 2023: Debt financing, amount not disclosed.20142026Debt financingamount not disclosed2 rounds
Show as table
Rounds2
Axis2014 to 2026
Debt financing · 20 Apr 2023not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at PT Etana Biotechnologies Indonesia?

417 counted staff profiles at January 2026, inside the self-reported 201–500 band.

Where does PT Etana Biotechnologies Indonesia have offices?

One address on record, Indonesia only. Primary: Jl. Rawa Gelam V Blok L Kav 11-13 Kel. Jatinegara Kec. Cakung Kawasan Industri Pulogadung Jakarta Timur 13930, Jakarta 13930.

Has PT Etana Biotechnologies Indonesia raised funding?

Two rounds. Latest 20 April 2023: debt financing, investor KFW DEG, no amount recorded.

Which companies are listed alongside PT Etana Biotechnologies Indonesia?

Eight peer profiles on record: PT. Pharos Indonesia and PT Kalbe Farma, Tbk.